Hints and tips:
Related Special Reports
...Influencers affiliated with Ogilvy will need to clearly say when they are being paid by a pharma company....
...However, a Japanese executive from Astellas Pharma was arrested last year in China on suspicion of espionage....
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...Nippon Steel snapped up US Steel for $14.9bn last month. Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...Tokyo has argued that the measure was not targeted at China, but Beijing views it as in alignment with US steps to cut off China’s access to tools needed to manufacture advanced chips....
...Japan has said 17 of its citizens have been detained since China passed a counter-espionage law in 2014, of whom five remain in detention, including an executive of Astellas Pharma who was taken into custody...
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...But trustbusters have fresh reasons to feel cross with the pharma industry. The US Federal Trade Commission now frowns on its “rampant consolidation”....
...Earlier this month, Johnson & Johnson and Japanese drugmaker Astellas Pharma filed lawsuits against the Biden administration’s reforms, following on from legal challenges filed by Merck, Bristol Myers Squibb...
...It will acquire the rights to sell it in the US, where there is a $15bn market for IBD, and in Japan....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Some pharma companies disputed the annual cost figures published by the health department....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Healthcare spending accounts for about a fifth of US economic output. Competition authorities want to restrain its cost growth....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
...US....
...Mintz and apprehended local staff, detained a senior executive from Japan’s Astellas Pharma group and hit London-headquartered Deloitte with a record fine....
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
...’s Astellas Pharma on espionage charges....
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
International Edition